|
Volumn 25, Issue 4, 2011, Pages 213-222
|
Screening for metabolic syndrome in long-term psychiatric illness: Audit of patients receiving depot antipsychotic medication at a psychiatry clinic
|
Author keywords
Antipsychotic agents; Cardiovascular diseases; Clinical audit; Mental disorders; Metabolic syndrome X; Quality improvement
|
Indexed keywords
AMISULPRIDE;
ARIPIPRAZOLE;
CHLORPROMAZINE;
CLOZAPINE;
FLUPHENAZINE DECANOATE;
GLUCOSE;
HALOPERIDOL;
HIGH DENSITY LIPOPROTEIN;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
SULPIRIDE;
TRIACYLGLYCEROL;
ZUCLOPENTHIXOL DECANOATE;
ADULT;
AGED;
ARTICLE;
BODY WEIGHT;
CONTROLLED STUDY;
DYSLIPIDEMIA;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
IRELAND;
MAJOR CLINICAL STUDY;
MALE;
MASS SCREENING;
MEDICAL AUDIT;
MENTAL DISEASE;
MENTAL HOSPITAL;
METABOLIC SYNDROME X;
MORBIDITY;
OBESITY;
OUTCOME ASSESSMENT;
OUTPATIENT;
RISK FACTOR;
SYSTOLIC BLOOD PRESSURE;
TRIACYLGLYCEROL BLOOD LEVEL;
WAIST CIRCUMFERENCE;
|
EID: 84857536536
PISSN: 02136163
EISSN: None
Source Type: Journal
DOI: 10.4321/S0213-61632011000400004 Document Type: Article |
Times cited : (11)
|
References (17)
|